Clinical Trial Update: An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rosuvastatin in children and adolescents with familial hypercholesterolemia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Familial Hypercholesterolaemia | Phase 3 | Status: COMPLETED | Results posted: 2015-02-02